Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(11%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
1
11%
Ph not_applicable
8
89%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting1
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

completed667%
recruiting111%
terminated111%
enrolling_by_invitation111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9